Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy

Shah et al.

  • Blood Advances
  • August 2019

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor- induced encephalitis

Johnson et al.

  • Nature Medicine
  • July 2019

Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity

Kuehm et al.

  • Cancer Immunology and Immunotherapy
  • May 2019

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Voorwerk et al.

  • Nature Medicine
  • May 2019

Rational design of anti-GITR-based combination immunotherapy

Zappasodi et al.

  • Nature Medicine
  • April 2019

Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States

Wei et al.

  • Immunity
  • April 2019

Mobilization of CD8þ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

Seo et al.

  • Clinical Cancer Research
  • April 2019

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma

Agdashian et al.

  • Cancer Immunology and Immunotherapy
  • April 2019

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Cloughesy et al.

  • Nature Medicine
  • March 2019